Follow-up of a major linkage peak on chromosome 1 reveals suggestive QTLs associated with essential hypertension: GenNet study

Essential hypertension is a major cardiovascular risk factor and a large proportion of this risk is genetic. Identification of genomic regions consistently associated with hypertension has been difficult in association studies to date as this requires large sample sizes.We previously published a large genome-wide linkage scan in Americans of African (AA) and European (EA) descent in the GenNet Network of the Family Blood Pressure Program (FBPP). A highly significant linkage peak was identified on chr1q spanning a region of 100 cM. In this study, we genotyped 1569 SNPs under this linkage peak in 2379 individuals to identify whether common genetic variants were associated with blood pressure (BP) at this locus.Our analysis, using two different family-based association tests, provides suggestive evidence (P≤2 × 10−5) for a collection of single nucleotide polymorphisms (SNPs) associated with BP. In EAs, using diastolic BP as a quantitative phenotype, three variants located in or near the GPA33, CD247, and F5 genes, emerge as our top hits; for systolic BP, variants in GPA33, CD247, and REN are our best findings. No variant in AAs came close to suggestive evidence after multiple-test corrections (P≥8 × 10−5).In summary, we show that systematic follow-up of a linkage signal can help discover candidate variants for essential hypertension that require a follow-up in yet larger samples. The failure to identify common variants is either because of low statistical power or the existence of rare coding variants in specific families or both, which require additional studies to clarify.

[1]  Jan A Staessen,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension , 1997, The Lancet.

[2]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[3]  N. Schork,et al.  A genome-wide linkage analysis investigating the determinants of blood pressure in whites and African Americans. , 2003, American journal of hypertension.

[4]  E. Boerwinkle,et al.  Multiple genes for essential-hypertension susceptibility on chromosome 1q. , 2007, American journal of human genetics.

[5]  Fuli Yu,et al.  Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay. , 2005, Genome research.

[6]  Nuala A Sheehan,et al.  Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressure , 2005, Statistics in medicine.

[7]  R. Klausner,et al.  Molecular cloning of the zeta chain of the T cell antigen receptor. , 1988, Science.

[8]  H. Brunner,et al.  Aliskiren: the first renin inhibitor for clinical treatment , 2008, Nature Reviews Drug Discovery.

[9]  Ronald W. Davis,et al.  Multiplexed genotyping with sequence-tagged molecular inversion probes , 2003, Nature Biotechnology.

[10]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[11]  M. Margaglione,et al.  The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both. , 2000, British journal of haematology.

[12]  F. Triposkiadis,et al.  Resistance to activated protein C and FV leiden mutation in patients with a history of acute myocardial infarction or primary hypertension. , 2000, American journal of hypertension.

[13]  P. Hardenbol,et al.  Optimal genotype determination in highly multiplexed SNP data , 2006, European Journal of Human Genetics.

[14]  R. Moritz,et al.  The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Martin G. Larson,et al.  Does the Relation of Blood Pressure to Coronary Heart Disease Risk Change With Aging?: The Framingham Heart Study , 2001, Circulation.

[16]  Eric Boerwinkle,et al.  Replication of the Wellcome Trust genome-wide association study of essential hypertension: the Family Blood Pressure Program , 2008, European Journal of Human Genetics.

[17]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[18]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[19]  E. O’Brien,et al.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. , 1997, Lancet.

[20]  Christoph Lange,et al.  A multivariate family-based association test using generalized estimating equations: FBAT-GEE. , 2003, Biostatistics.

[21]  Steven C. Hunt,et al.  Multi-center genetic study of hypertension: The Family Blood Pressure Program (FBPP). , 2002, Hypertension.

[22]  G. Abecasis,et al.  Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.

[23]  A. Stanton,et al.  Renin Gene Polymorphisms and Haplotypes, Blood Pressure, and Responses to Renin-Angiotensin System Inhibition , 2007, Hypertension.

[24]  P. Wilson,et al.  Established risk factors and coronary artery disease: the Framingham Study. , 1994, American journal of hypertension.